June Margaret Sun

June Margaret Sun

Auto-generated profile, based on publicly available information

June Margaret Sun

Cardiovascular Endocrinology Laboratory, Baker Heart and Diabetes Institute, Melbourne Victoria, Australia

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SDSophia Davidson
Sophia Davidson
YSYuri Shibata
Yuri Shibata
SCSophie Collard
Sophie Collard
HZHongyu Zheng
Hongyu Zheng
KKKlara Kong
Klara Kong
SMSeth L. Masters
Seth L. Masters
OTU deubiquitinase with linear linkage specificity (OTULIN) regulates inflammation and cell death by deubiquitinating linear ubiquitin chains generated by the linear ubiquitin chain assembly complex (LUBAC). Biallelic loss-of-function mutations causes OTULIN-related autoinflammatory syndrome (ORAS), while OTULIN haploinsuffiency has not been associated with spontaneous inflammation. However, herein, we identify two patients with the heterozygous mutation p.Cys129Ser in OTULIN. Consistent with ORAS, we observed accumulation of linear ubiquitin chains, increased sensitivity to TNF-induced death, and dysregulation of inflammatory signaling in patient cells. While the C129S mutation did not affect OTULIN protein stability or binding capacity to LUBAC and linear ubiquitin chains, it did ablate OTULIN deubiquitinase activity. Loss of activity facilitated the accumulation of autoubiquitin chains on LUBAC. Altered ubiquitination of LUBAC inhibits its recruitment to the TNF receptor signaling complex, promoting TNF-induced cell death and disease pathology. By reporting the first dominant negative mutation driving ORAS, this study expands our clinical understanding of OTULIN-associated pathology.

1 June 2001 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
WAWy Au
Wy Au
JHJc Ho
Jc Ho
ALAk Lie
Ak Lie
JSJ Sun
J Sun
LZL Zheng
L Zheng
KTKw Tsang
Kw Tsang

19 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JSJune Margaret Sun
June Margaret Sun
ATAlejandro Torres
Alejandro Torres
JHJoshua Hor
Joshua Hor
DDDan Donner
Dan Donner
HKHelen Kiriazi
Helen Kiriazi
MYMorag J. Young
Morag J. Young
Background: Heart failure with preserved ejection fraction (HFpEF) accounts for more than half of all heart failure cases and is a major cause of morbidity and mortality worldwide. However, existing preclinical models often do not capture the heterogeneity, sex-specific and cardiometabolic features that characterise the clinical syndrome. Our goal was to develop an model of HFpEF in mature female mice. Methods and Results: Female and male C57BL/6J mice (>24 weeks) were exposed to a high-fat diet (HFD) combined with low-dose (0.3 g/L; female only) or high-dose (0.5 g/L; female and male) nitric oxide synthase (NOS) inhibition using N(ω)-nitro-L-arginine methyl ester (L-NAME) for 15 weeks. Female mice receiving 0.3 g/L L-NAME+HFD developed an HFpEF-like phenotype with glucose intolerance, reduced exercise capacity and impaired ventricular filling, including reduced E-wave velocity, E/A ratio and E-wave deceleration rate; ejection fraction (EF) and global longitudinal strain (GLS) remained unchanged versus female controls. Increasing NOS inhibition did not enhance the HFpEF-like phenotype but was associated with a transcriptional profile enriched for inflammatory, cellular-stress and mitochondrial homeostasis pathways. In contrast, male mice receiving 0.5 g/L L-NAME+HFD developed hypertension, elevated ventricular pressures and systolic dysfunction. Circulating lipidomic profiling demonstrated conserved sphingolipid and phospholipid remodelling across treatment groups despite different cardiac phenotypes. Conclusions: Combining HFD-induced metabolic stress with modest NOS inhibition established an early HFpEF-like phenotype in mature female mice characterised by glucose intolerance, reduced exercise capacity and impaired ventricular filling. This model may serve as a platform for evaluating therapeutic interventions for HFpEF before advanced fibrosis develops.

3 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJune Sun
June Sun
ATAlejandro Torres
Alejandro Torres
JHJoshua Hor
Joshua Hor
DDDan Donner
Dan Donner
HKHelen Kiriazi
Helen Kiriazi
MYMorag J. Young
Morag J. Young
Background: Heart failure (HF) with preserved ejection fraction (HFpEF) is a heterogeneous condition that accounts for more than half of all HF cases. It is a major cause of morbidity and mortality worldwide; however, preclinical models often do not capture the heterogeneity and sex-specific and cardiometabolic features observed in patients. We hypothesised that biological sex and the degree of nitric oxide synthase (NOS) inhibition would influence development of HFpEF-like versus HFrEF-like phenotypes. Methods and Results: Male and female C57BL/6J mice (>24 weeks) were exposed to a high-fat diet (HFD) combined with low-dose (0.3 g/L; female only) or high-dose (0.5 g/L; male and female) NOS inhibition using N(ω)-nitro-L-arginine methyl ester (L-NAME) for 15 weeks. Female mice receiving low-dose L-NAME+HFD developed a HFpEF-like phenotype characterised by impaired diastolic function, exercise intolerance and preserved systolic function. Increasing NOS inhibition did not worsen diastolic dysfunction but induced inflammatory and stress-associated transcriptional pathways in female hearts. In contrast, male mice administered high-dose L-NAME+HFD developed hypertension, elevated ventricular pressures and impaired systolic function, consistent with a HFrEF-like phenotype. Despite different cardiac phenotypes, circulating lipidomic profiling revealed broadly conserved sphingolipid and phospholipid remodelling, with sex-specific regulation of phosphatidylinositol and lysophosphatidylcholine species. Transcriptomic analyses identified shared regulation of extracellular matrix, calcium-handling and metabolic pathways, whereas greater NOS inhibition was associated with transcriptional signatures related to inflammatory signalling, cellular stress responses and mitochondrial homeostasis. Conclusions: Cardiometabolic stress does not produce a uniform HF phenotype. Instead, biological sex and the degree of NOS inhibition direct distinct functional and molecular remodelling trajectories, identifying HFpEF-like dysfunction as one of several potential cardiac responses to cardiometabolic injury in male and female mice.